AMARIN CORP PLC\UK Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
AMARIN CORP PLC\UK (AMRN) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $439.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2018-02-27.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2018-02-27
- AMARIN CORP PLC\UK unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2015 was $439.00K, a 72.83% increase from fiscal 2014.
- AMARIN CORP PLC\UK unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2014 was $254.00K, a 0.78% decline from fiscal 2013.
- AMARIN CORP PLC\UK unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2013 was $256.00K, a 433.33% increase from fiscal 2012.
- AMARIN CORP PLC\UK unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2012 was $48.00K.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|
| 2015-12-31 | $439.00K 10-K · filed 2018-02-27 |
| 2014-12-31 | $254.00K 10-K · filed 2017-03-01 |
| 2013-12-31 | $256.00K 10-K · filed 2016-02-25 |
| 2012-12-31 | $48.00K 10-K · filed 2015-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |